Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

NLS Pharmaceutics (NLSP) SEC Filings & 10K Form

NLS Pharmaceutics logo
$2.63 -0.15 (-5.40%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$2.65 +0.02 (+0.76%)
As of 08/22/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/06/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
4:32 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
07/17/2025
8:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2025
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
6:31 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2025
3:57 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SCHEDULE 13D
06/23/2025
4:29 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
06/16/2025
6:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2025
6:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
06/10/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2025
7:54 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
05/01/2025
8:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form NT 20-F
04/15/2025
8:05 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
8:07 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
04/14/2025
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2025
4:23 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
03/31/2025
9:24 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
03/31/2025
8:29 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:20 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
One tiny company just cracked Google’s $19B problem (Ad)

An MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from a $63,000 luxury… into a 90-cent mass production reality. It’s 400x stronger than steel, conducts electricity better than copper… and just saved 379 lives in a single plane crash.tc pixel

One small U.S. company controls the only factory making it at scale.
12/30/2024
7:52 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/30/2024
5:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
12/23/2024
3:04 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K/A
12/03/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
11:15 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
3:30 PM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics (Subject)
NLS Pharmaceutics Ltd. (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
3:01 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/26/2024
3:40 PM		NLS Pharmaceutics (Filer)
NLS Pharmaceutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSP) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners
Nations are at war over what’s in this box
A resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...
Behind the Markets | Sponsoredtc pixel
Could This Be the End of Retirement Worries?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...
InvestorPlace | Sponsoredtc pixel
Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...
Weiss Ratings | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsoredtc pixel
Here's the last trade you should make before heading out for the weekend tomorrow.
On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...
Timothy Sykes | Sponsoredtc pixel